1. Scrip
  2. >>Business

Stallergenes Greer Back On The M&A Beat

 
• By John Davis

A leading allergy company in Canada has been snapped up by Stallergenes Greer, targeting North America as part of a renewed business development strategy.

House dust
Mites can be found in large numbers in house dust • Source: Shutterstock

The London, UK-headquartered allergy products company, Stallergenes Greer plc, has returned to being proactive in the allergy therapies sector by acquiring the Canadian company, Medic Savoure Ltd, for an undisclosed amount, just a week after having its marketing submission for its potential house dust mite (HDM) sublingual tablet product, STG320, accepted for review by Canadian regulators.

Although the size of the acquisition is modest – analysts estimate that Medic Savoure had annual sales of around €10m...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

Biogen Edges Closer To Growth On Strong Q2

 
• By Jessica Merrill

Sales of Leqembi, Zurzuvae and Skyclarys contributed to Biogen’s sales and earnings guidance raise, positioning the company closer to potential growth.

Amvuttra Makes Strong ATTR-CM Showing As Alnylam Prepares For Global Launches

 
• By Alaric DeArment

In an interview, chief commercial officer Tolga Tanguler gave some ideas of what to expect as the company prepares to launch the drug for ATTR-CM in Europe.

Argenx Powers Ahead With Vyvgart’s Prefilled Syringe Launch

 
• By Andrew McConaghie

The Netherlands-headquartered company is enjoying huge success with Vyvgart in two autoimmune conditions, with a new prefilled syringe version reaching more patient groups.